Home / Products / Oncology / Qimono / Infusion devices / Qimono Qimooctopus

Qimono Qimooctopus

Qimooctopus is a safe double-lumen IV extension tube allowing continuous infusion

Qimooctopus is a safe double-lumen IV extension tube allowing continuous infusion, intermittent injection and blood sampling. Its lateral line is fitted with Qimo female .
Qimo male has to be attached to the distal end of Qimooctopus. Qimoprime allows the priming of the line once Qimo male has been attached.

Product EAN: 3660812104852
Vygon Code: 7231.221

About Product

Qimono the complete closed system for safe delivery of cytotoxic drugs

Stay safe with Qimono

It is widely documented that exposure to Systemic Anti-Cancer Therapy (SACT), can pose a significant health risk to patients during treatment as well as healthcare workers involved in the preparation and administration of the drugs .

Many SACT agents are known to be carcinogenic, teratogenic and mutagenic. Exposure may be through skin contact, skin absorption, inhalation of aerosols and drug particles as well as ingestion and needlestick injuries. This can occur at various points of the treatment process: during the preparation of the medication, whilst the drugs are administered and after therapy .

Adverse health effects reported by chemotherapy nurses include headaches, dizziness, nausea and hair loss.

QimoOctopus with Qimo Female and Qimo Male is a multi-purpose catheter accessory, a double lumen IV extension tube with needleless connectors allowing intermittent injections or continuous infusions of fluids or medications.
IV extension tube in flexible, transparent polyurethane tubing with a low priming volume.
One lumen of QimoOctopus is fitted with a non-return valve, the other lumen is fitted with a Qimo Female connector.
The Qimo Male must be connected at the distal end of QimoOctopus.

QimoOctopus has the following advantages:
– Eliminates the risk of access-associated needle-stick injury.
– Reduces the risk of cannula movement in the vein causing mechanical vein irritation.
– Negates the need to use the cannula injection port (non disinfectable), Qimo Female is disinfectable.
– Eliminates the need to use a 3-way tap to run simultaneous compatible solutions.
– Provides closed system (avoiding blood reflux) when accessing the catheter.
– PUR material (no PVC, phthalate-free, no release of plasticizers).

Qimo Female is a multi-purpose, closed, needle-free, connection device with disinfectable membrane. See the corresponding technical file code 7210.02.

Qimo Male is a multi-purpose, closed, needle-free, I.V. connection device which has been designed for the preparation and safe administration of hazardous drugs. See the corresponding technical file code 7210.91.

QimoPrime is priming device. It is used to prime Qimo Male after Qimo Male has been attached onto the distal end of QimoOctopus. See the corresponding technical file code 7210.81.

Safe emergency access. Easy direct injection with a syringe close to the patient.

Composition of the device [description]
Components in contact with the solution:
– Male Luer-lock hub and disk in MABS
– Tube in PU
– Hub in PU
– Valve in PC and membrane in silicone

Qimo Male
– Internal conduit in PBT and membrane in silicone
– Safety lock in PP
– Lubricant silicone

Qimo Female
– Tube in stainless steel
– Membrane in polyisoprene
– Male Luer-lock connector in PC
– Lubricant silicone

UOI Units: Box

UOI: 50

Contains Latex: No

Contains DEHP: No

Pyrogen Free: Yes

Sterile Medical Device: Yes

Product Support

Vygon is committed to education and support for our customers. We provide in-service training sessions for all staff and all shift patterns, to help ensure your clinicians achieve best practice when delivering care to patients. In addition, patient advice leaflets and children’s bravery certicates are available on request, to help assist the clinicians in supporting and informing their patients.

Supporting Documents Download:

Contact Us

Events

There are currently no related events to this product.

Related Products

News

NIOSH Testing Success for Vygon’s CSTD Qimono

Tests to evaluate the effectiveness of closed system transfer devices (CSTD) in preventing exposure to dangerous chemotherapy drugs, has proven Vygon’s Qimono exceeds the rigorous NIOSH standards.

Read More

USP 800: A new standard of safety for US nurses

From 1st December this year American nurses handling hazardous drugs whilst treating cancer patients are legally protected by new standards covered by USP 800 guidelines.

Read More

Sact Safety Campaign Update

SACT Safety Campaign Update November 22nd 2019 Three years on from presenting their initial work into the safety risks facing …

Read More